![[ Back to EurekAlert! ]](http://www.eurekalert.org/images/back2e.gif){kind=small}
|
Contact: Siobhan E. Gallagher
siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus
Caption: Degterev, Yuan and colleagues have discovered that RIP1 kinase is a specific cellular target of necrostatins, unique small molecules previously shown to reduce damage from necrosis.
Credit: Alexei Degterev
Usage Restrictions: For media use only.
Related news release: Stopping unwanted cell death: Implications for drug discovery
|